| http://www.w3.org/ns/prov#value | - nc.using an exogenously-derived colony-stimulating factor 5 hyaluronidase (CSF5hyaluronidase) for treatment of myelosuppression as may occur after irradiation, chemotherapy or other diseases where an increase in leukocyte levels may be beneficialUS77674295 Mar 20043 Ago 2010Halozyme, Inc.use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated f
|
